(0.09%) 5 522.00 points
(0.12%) 39 891 points
(0.22%) 19 795 points
(0.01%) $81.64
(0.46%) $2.82
(-0.32%) $2 336.80
(-0.05%) $29.51
(0.21%) $1 003.90
(0.00%) $0.931
(0.00%) $10.53
(0.01%) $0.788
(-0.85%) $87.25
-0.11% $ 4.38
Live Chart Being Loaded With Signals
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs...
Stats | |
---|---|
Dzisiejszy wolumen | 35 772 |
Średni wolumen | 8 661 |
Kapitalizacja rynkowa | 14.07M |
EPS | $-0.580 ( Q2 | 2024-05-10 ) |
Następna data zysków | ( $0 ) 2024-08-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.220 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-03 | Nijhawan Pardeep | Buy | 4 785 | Common Shares |
2024-05-01 | Nijhawan Pardeep | Buy | 3 083 | Common Share |
2024-04-01 | Nijhawan Pardeep | Buy | 3 253 | Common Shares |
2024-03-25 | Nijhawan Pardeep | Buy | 5 000 | Common Shares |
2024-03-01 | Nijhawan Pardeep | Buy | 2 765 | Common Shares |
INSIDER POWER |
---|
77.77 |
Last 96 transactions |
Buy: 2 359 632 | Sell: 304 857 |
Edesa Biotech Inc Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Edesa Biotech Inc Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-183 471 (0.00 %) |
EPS: | $-2.93 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-183 471 (0.00 %) |
EPS: | $-2.93 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-118 188 (0.00 %) |
EPS: | $-1.050 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.100 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Edesa Biotech Inc
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej